L-Arginine
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Compound | L-Arginine |
|---|---|
| Chemical class | Conditionally essential α-amino acid — guanidinium side chain, cationic at physiological pH |
| CAS | 74-79-3 (free base) · 1119-34-2 (hydrochloride) |
| Primary source | Microbial fermentation, typically Corynebacterium species on a carbohydrate substrate |
| Key applications | Nitric oxide synthesis, urea cycle, creatine and polyamine precursor, growth hormone secretion |
| Claim strength | Moderate in clinical deficiency states; Emerging for oral performance and vascular claims |
| Typical form | Crystalline free base or hydrochloride at 99%; also as AAKG and arginine aspartate |
| Buy from Herbuno | L-Arginine 99% Powder · L-Arginine HCl 99% · L-Arginine AKG 2:1 · L-Arginine L-Aspartate |
| Origin | Processed / Sourced from India |
| MOQ | R&D 100 g / 250 g (subject to stock) · Pilot batch 1–5 kg · Bulk 10 kg, 25 kg and above |
| Lead Time | Dispatch within 72 hrs from stock · fresh-batch production (typically 50 kg+): 10 working days |
| Documentation | CoA & MSDS standard with every lot |
Name origin: From the Latin argentum, silver — Ernst Schulze isolated it from lupin seedlings in 1886 as a silver nitrate salt and named it for the crystals rather than for anything about its biology. The guanidinium group that gives arginine its distinctive chemistry also gives it the highest pKa of any amino acid side chain, meaning it carries a positive charge across the entire physiological range.
Discovery and production history: Arginine's prominence rests on a discovery made a century after its isolation. The identification of nitric oxide as the endothelium-derived relaxing factor, work recognised by the 1998 Nobel Prize in Physiology or Medicine, established arginine as the substrate for nitric oxide synthase and created the entire vascular supplement category built around it. Industrial production moved from protein hydrolysis to microbial fermentation during the twentieth century, as with the other commodity amino acids.
Research trajectory: The field has had to absorb an uncomfortable finding. The logic that supplying more substrate should produce more nitric oxide is clean, and early intravenous studies supported it. Oral supplementation proved far less effective, and the reason turned out to be pharmacokinetic rather than biological: arginase in the intestinal mucosa and liver degrades a large proportion of an oral dose before it reaches the circulation. Attention consequently shifted to citrulline, which escapes that first-pass metabolism and is converted to arginine in the kidney — and which raises plasma arginine more effectively than arginine itself.
Commercial source: Supplement and pharmaceutical arginine is produced by fermentation using Corynebacterium or related organisms on a glucose or sucrose substrate, then crystallised and purified. It is available as the free base, which is strongly alkaline, or as the hydrochloride, which is near-neutral and easier to formulate. Combination salts such as arginine alpha-ketoglutarate and arginine aspartate are manufactured for specific applications, though the evidence that they outperform plain arginine is thin.
Evidence for L-Arginine Applications
The first-pass problem is the central fact and it undercuts most consumer positioning. Arginase in the intestinal mucosa and in the liver degrades a substantial fraction of oral arginine to ornithine and urea before it reaches systemic circulation. Measured bioavailability of oral arginine is modest and highly variable between individuals, and large single doses provoke gastrointestinal distress before they meaningfully raise plasma concentrations. This is why intravenous arginine produces vascular effects that oral arginine struggles to reproduce, and it is the single most important thing a formulator should understand about this ingredient. Claim strength: High.
Citrulline raises plasma arginine more effectively than arginine does, which is a genuinely counterintuitive result and worth stating plainly even though we sell both. Citrulline is not a substrate for arginase, passes the intestine and liver intact, and is converted to arginine in the renal proximal tubule. Head-to-head studies comparing equivalent oral doses find citrulline produces higher and more sustained plasma arginine. A formulator whose objective is raising arginine availability for the nitric oxide pathway has a better tool than arginine, and should know that before specifying. Claim strength: High.
Exercise performance and the pump claim have weak support at oral doses. Trials of oral arginine on strength, power, endurance and blood flow in healthy trained individuals have produced mixed and mostly unimpressive results, consistent with the bioavailability problem. Arginine alpha-ketoglutarate, developed specifically for this market, has not demonstrated superiority over plain arginine in controlled comparison. Where vascular effects are the objective, nitrate-based approaches and citrulline both have better supporting data. Claim strength: Emerging, trending negative.
Clinical applications are where arginine holds up, and they are specific rather than general. Arginine becomes conditionally essential in trauma, sepsis, burns and major surgery, where endogenous synthesis cannot meet demand, and immunonutrition formulas containing arginine have shown reductions in infectious complications and length of stay in surgical patients. There is a genuine caution attached: arginine supplementation in septic patients has been debated because of concerns around nitric oxide-mediated vasodilation in an already hypotensive state, and practice is not uniform. Arginine is also used in inherited urea cycle disorders, which is a pharmaceutical indication. Claim strength: Moderate.
The lysine and herpes interaction is well established in virology and modest in clinical effect. Herpes simplex replication requires arginine, and lysine competes with arginine for intestinal transport and renal reabsorption. This is the basis for lysine supplementation in recurrent herpes and for the conventional advice to limit arginine-rich foods. A high-dose arginine product carries a reasonable precaution for people with frequent recurrences, which is rarely stated on label and arguably should be. Claim strength: Moderate.
Formulation safety is generally good with route-specific cautions. Oral doses up to around 6 grams daily are well tolerated; higher doses commonly cause nausea, cramping and diarrhoea through osmotic effects rather than toxicity. No tolerable upper intake level has been established. The meaningful caution is post-myocardial-infarction, where a trial of supplemental arginine was stopped early after higher mortality in the arginine arm — a finding that should keep arginine out of products targeted at cardiovascular patients, however appealing the nitric oxide rationale sounds in that context. Claim strength: Moderate.
Sourcing L-arginine from Herbuno. We supply arginine as the 99% free base, as the hydrochloride, and as the AKG and aspartate combination salts.
If your objective is raising arginine availability for the nitric oxide pathway, discuss citrulline with us before specifying arginine — it does that job better, and we would rather tell you now than after a formulation is locked. All lots ship with CoA and MSDS as standard; request a quotation for pilot or bulk volumes.
Dosage & Formulator Specification
The free base is 100% arginine; the hydrochloride is roughly 83% arginine by weight, so 6 grams of arginine HCl delivers about 5 grams of arginine. Combination salts differ again: arginine alpha-ketoglutarate at a 2:1 ratio and arginine aspartate each carry their own arginine fraction, and these are often dosed as though equivalent to the free base, which overstates delivery. Always calculate on arginine content rather than on total salt weight.
Trial doses for vascular and performance endpoints have typically run 3 to 6 grams daily, sometimes in divided doses. The practical ceiling is gastrointestinal rather than toxicological: single doses above roughly 9 grams commonly produce nausea and osmotic diarrhoea, which limits what a single-serve format can carry. Clinical immunonutrition formulas use considerably higher amounts under supervision. Given the bioavailability problem, pushing the dose is a poor strategy — the constraint is first-pass arginase, not the amount ingested.
Form selection is largely a pH decision. Arginine free base is strongly alkaline, with a solution pH around 11, which makes it unsuitable for most beverages, aggressive toward acid-sensitive co-ingredients, and unpleasant in flavour systems. The hydrochloride is near-neutral and far easier to work with, at the cost of a lower arginine fraction and a saline note. Arginine is hygroscopic in both forms and needs moisture control in storage and in powder blends. It is freely soluble in water. In combination with reducing sugars it participates in Maillard browning on heating, which matters for bars and thermally processed formats.
For analytical control, specify identity and assay by HPLC or ion-exchange chromatography with optical rotation to confirm the L-configuration, since D- and DL- material is cheaper and nutritionally inert. Standard amino acid specifications should cover heavy metals, residual solvents, microbiological limits and loss on drying, and for fermentation-derived material the certificate should name the production organism and the substrate, which is what determines vegan, non-GMO, kosher and halal eligibility. Arginine is fermentation-derived rather than plant-extracted, so phytosanitary certification does not apply; CoA and MSDS ship as standard.
If a formulation is being designed around the nitric oxide pathway rather than around arginine specifically, the specification conversation is worth having before the dose is fixed rather than after. The practical options differ in cost, tolerability and evidence: citrulline at 3 to 6 grams, dietary nitrate sources, or arginine at a dose the gut will accept. Each behaves differently in a flavour system and each carries a different label story. We would rather be part of that conversation at the formulation stage than supply a specification that turns out to be the weakest of the three routes to the same endpoint.
Frequently Asked Questions — L-Arginine
Why doesn't oral arginine work as well as expected?
Arginase in the intestinal mucosa and liver degrades a large fraction of an oral dose before it reaches circulation. Measured bioavailability is modest and varies a lot between people, and large single doses cause gastrointestinal distress before they meaningfully raise plasma levels. This is why intravenous arginine produces vascular effects that oral arginine struggles to reproduce.
Should I use citrulline instead?
If your objective is raising plasma arginine for the nitric oxide pathway, yes. Citrulline is not an arginase substrate, passes the gut and liver intact, and converts to arginine in the kidney. Head-to-head studies at equivalent oral doses find it produces higher and more sustained plasma arginine than arginine itself. We sell both and would still tell you this.
Is AAKG better than plain arginine?
It has not demonstrated superiority in controlled comparison, despite being developed specifically for the sports market. It also carries a lower arginine fraction per gram than the free base, and is frequently dosed as though equivalent. Calculate on arginine content.
Free base or hydrochloride?
Hydrochloride for almost any beverage or flavoured format — the free base has a solution pH around 11, which is hard on acid-sensitive co-ingredients and unpleasant to taste. The trade-off is that HCl is about 83% arginine by weight and carries a saline note. Both are hygroscopic and need moisture control.
Are there people who should avoid arginine?
Two groups worth noting. People with frequent herpes simplex recurrences, since the virus requires arginine to replicate and lysine competes with it — a high-dose arginine product warrants a precaution that is rarely on label. And post-myocardial-infarction patients: a trial of supplemental arginine in that population was stopped early after higher mortality in the arginine arm.
Why source arginine from India?
Roughly 80% of raw nutraceutical ingredients originate in China, and amino acids are among the most concentrated categories, so a qualified second origin is a continuity measure. India has established fermentation capacity and the certification infrastructure for the vegan, non-GMO, kosher and halal documentation this category usually requires.